Trial Profile
A Randomized, Double-blind, Placebo-controlled and Open Label Active-controlled, 4-period Crossover Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization in Healthy Adult Men and Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jan 2015
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Bial
- 08 Nov 2014 New trial record